戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n was initiated with a crystalloid solution (Lactated Ringers).
2 ed had opposite effects in outcome, favoring Lactated Ringer.
3 pensive and less efficacious than the use of lactated Ringer.
4  component analysis suggested that volume of Lactated Ringer and 0.9% saline infused had opposite eff
5       Balanced crystalloid solutions such as Lactated Ringer are associated with less acidosis and ma
6 lower in the PJ34-treated groups than in the Lactated Ringer group at 7 and 24 hours of reperfusion.
7 d controlled trial (NCT 01428050), comparing lactated Ringers (LAR) (15 mL/kg/hr LAR intraoperation,
8 24-hour period; the untreated group received Lactated Ringer (LR) at the same time points.
9 n (UW) solution versus room temperature (RT) lactated ringers (LR) solution.
10 in was added to the storage solution and the lactated Ringer poststorage rinse solution.
11  in the patients who received HES 130/0.4 or lactated Ringer, respectively (P < 0.038).
12 tation to normal blood pressure with a blood/lactated Ringer's (1:2) mixture.
13 th PNPH or Hextend required less volume than lactated Ringer's (both p<.05).
14 e forearm and each randomly assigned as: (1) lactated Ringer's (control); (2) 20 mm Nomega-nitro-l-ar
15 mized to receive either SAAP with oxygenated lactated Ringer's (LR) solution (n = 6) or SAAP with oxy
16  whole blood (FWB), (2) SAAP with oxygenated lactated Ringer's (LR), 1,600 mL/2 min, or (3) SAAP with
17  polymerized human hemoglobin (PolyhHb), and lactated Ringer's (LR).
18 citation of hemorrhage using 3% NaCl (HS) or lactated Ringer's (LR).
19 r 0.9% saline (n = 25), Hextend (n = 25), or lactated Ringer's (n = 10).
20 nd improved mean arterial blood pressure vs. lactated Ringer's (p<.05).
21                       Mice were treated with lactated Ringer's (vehicle) solution, monophosphoryl lip
22 aroscopically and flushed with cold heparin, lactated Ringer's and procaine (HeLP) solution.
23                                  Infusion of lactated Ringer's demonstrated no changes in the measure
24 lbumin group and 83 of 180 (46%) died in the lactated Ringer's group (p = 0.2).
25 lbumin group and 40 of 180 (22%) died in the lactated Ringer's group (p = 0.5).
26 alysis, participants were categorized into a lactated Ringer's group and a 0.9% saline group based on
27 red in 76 of 622 participants (12.2%) in the lactated Ringer's group and in 110 of 690 participants (
28                          The patients in the lactated Ringer's group, however, received more fluid (P
29 nic saline group compared with the Isosal or lactated Ringer's groups (p = .001).
30 albumin to early standard resuscitation with lactated Ringer's in cancer patients with sepsis did not
31 to restore mean arterial blood pressure than lactated Ringer's or Hextend and confer neuroprotection
32 baseline, after each blood withdrawal, after lactated Ringer's resuscitation, and after infusion of s
33 rapid intravenous strategy that consisted of lactated Ringer's solution (100 ml per kilogram of body
34 ne (14 +/- 2 mL/mg) groups compared with the lactated Ringer's solution (35 +/- 5 mL/kg) group.
35  At t = 60 mins, pigs were resuscitated with lactated Ringer's solution (40 mL/kg over 30 mins).
36 1.7 mL/kg for Isosal solution) compared with lactated Ringer's solution (75.3 +/- 11.6 mL/kg) (p = .0
37 4 (intervention group) or an equal volume of lactated Ringer's solution (acid control group).
38 bin (HBOC), sildenafil (PDE5 inhibitor), and lactated Ringer's solution (control).
39 (n = 6), 0.9% saline (n = 6), 5% dextrose in lactated Ringer's solution (D5RL) (n = 6), or 5% dextros
40  bovine hemoglobin) or a control infusion of lactated Ringer's solution (each infusion given over a t
41 P dissolved in lactated Ringer's solution or lactated Ringer's solution (LR) alone were given by intr
42 matic hypovolemic shock, HSD (250 mL) versus lactated Ringer's solution (LR) as the initial resuscita
43 ected to CLP-induced sepsis and treated with lactated Ringer's solution (LR, n = 13) survived longer
44 reas another group (n = 8) received only the lactated Ringer's solution (LRS) vehicle.
45 domized to receive a 1-hr infusion of either lactated Ringer's solution (n = 6), 0.9% saline (n = 6),
46 served by blood plus albumin than blood plus lactated Ringer's solution (P < 0.01).
47 administration than after resuscitation with lactated Ringer's solution (p < 0.05).
48 ion-reperfusion than after administration of lactated Ringer's solution (p < 0.05).
49 ther resuscitation with red blood cells plus lactated Ringer's solution (RL) is more effective than R
50 ns from 48 medical ICU patients receiving no lactated Ringer's solution (RL).
51 n (shed blood + 0.12, 0.24, or 0.36 g/kg) or lactated Ringer's solution (shed blood + 2 x volume of s
52 s were subsequently either resuscitated with lactated Ringer's solution (three times shed blood volum
53  The shed blood was then returned along with lactated Ringer's solution (two times the shed blood vol
54        Controls (n = 6) received intravenous lactated Ringer's solution according this dosing schedul
55  during reperfusion compared with albumin or lactated Ringer's solution administration (p < .001).
56 meter returned to baseline immediately after lactated Ringer's solution administration, while PAOP re
57 ance decreased transiently immediately after lactated Ringer's solution administration.
58 istration, and immediately and 30 mins after lactated Ringer's solution administration.
59  to the iron chelator deferoxamine (DFO), or lactated Ringer's solution alone (LR) on lung injury par
60 f albumin in a lactated Ringer's solution or lactated Ringer's solution alone during the first 6 hour
61 Thus, 16 patients were randomized to receive lactated Ringer's solution and 17 to receive HES 130/0.4
62 ter the index admission was 20.3+/-3.5% with lactated Ringer's solution and 21.4+/-3.3% with normal s
63                                              Lactated Ringer's solution and 3-hr cold ischemia time w
64 d in the CLOVERS trial, 622 (39.8%) received lactated Ringer's solution and 690 (44.1%) received 0.9%
65 lues (140 to 145 mmol/L) was measured in the lactated Ringer's solution and hetastarch groups (130 to
66 d edema in nonburned skin compared with both lactated Ringer's solution and hypertonic saline dextran
67 rol livers were similarly perfused with cold lactated Ringer's solution and were followed without imm
68 rimary estimand was the effect of the use of lactated Ringer's solution as compared with normal salin
69 t resuscitation in all three groups was with lactated Ringer's solution as needed to maintain baselin
70              All groups received intravenous lactated Ringer's solution at 4 mL.kg-1.%burn(-1).24 hrs
71 ruvate (n = 9) solution made up exactly like lactated Ringer's solution except for the substitution o
72 ith four times the volume of shed blood with lactated Ringer's solution for 60 mins.
73 nt in the isosal group was lower than in the lactated Ringer's solution group only in the cerebellum.
74 he hypertonic saline group compared with the lactated Ringer's solution group.
75                           Patients receiving lactated Ringer's solution had more hospital-free days a
76                   The short-term infusion of lactated Ringer's solution in normal adults (hemodynamic
77  All dogs were resuscitated by administering lactated Ringer's solution intravenously to achieve and
78                                      Whether lactated Ringer's solution is clinically superior to nor
79  evidence suggests that balanced fluids like Lactated Ringer's solution may be preferable.
80 gned to receive either bolus of albumin in a lactated Ringer's solution or lactated Ringer's solution
81               Three doses of EP dissolved in lactated Ringer's solution or lactated Ringer's solution
82  hospitals in Ontario, Canada, to use either lactated Ringer's solution or normal saline hospital-wid
83  sodium chloride) and balanced crystalloids (lactated Ringer's solution or Plasma-Lyte A).
84 ur times the volume of maximal bleedout with lactated Ringer's solution over 60 mins.
85 d with 4 times the volume of shed blood with lactated Ringer's solution over 60 minutes.
86 ed by more than 50%, while administration of lactated Ringer's solution provoked an approximately 2.5
87         A hospital-wide policy to administer lactated Ringer's solution rather than normal saline did
88 ntly greater (p < .001) in animals receiving lactated Ringer's solution than in rabbits receiving eit
89 ventilation, awakened, and resuscitated with lactated Ringer's solution titrated to maintain hematocr
90 ons were compared between subjects receiving lactated Ringer's solution vs. subjects receiving normal
91 e points studied in those subjects receiving lactated Ringer's solution vs. those persons receiving n
92 on (25, 50, or 100 mg/kg) or equal volume of lactated Ringer's solution was infused on day 1; the alt
93 itial 10-mL/kg test solution dose was given, lactated Ringer's solution was infused to achieve the sa
94                            In contrast, when lactated Ringer's solution was used, multiple boluses we
95             After recovery, Intralipid 20 or Lactated Ringer's Solution were infused according to a c
96 s with a large body surface area burn, using lactated Ringer's solution, 6% hetastarch, and hypertoni
97             Initial fluid resuscitation with lactated Ringer's solution, compared with 0.9% saline, m
98 re phosphate-buffered saline, normal saline, lactated Ringer's solution, dextran, hespan, 5% human al
99                         After perfusion with lactated Ringer's solution, extravasated bBSA was detect
100 Hemorrhaged rats were then resuscitated with lactated Ringer's solution, four times the maximum shed
101           Test solutions (10 mL/kg of either lactated Ringer's solution, hetastarch, or hypertonic sa
102 d us to test the hypothesis that intravenous lactated Ringer's solution, infused at a rate used in re
103                         This was followed by lactated Ringer's solution, infused to a target urine ou
104 -controlled infusion pumps to deliver blood, lactated Ringer's solution, norepinephrine, and in ReFit
105  previously discovered that small amounts of lactated Ringer's solution, which are inadequately clear
106 eperfusion, during which either PentaLyte or lactated Ringer's solution-based resuscitation was admin
107 d, 2400 mosm/L of 7.5% hypertonic saline, or lactated Ringer's solution.
108  by 48% and 74%, respectively, compared with lactated Ringer's solution.
109 ed aggressive or moderate resuscitation with lactated Ringer's solution.
110  placed on ventilators and resuscitated with lactated Ringer's solution.
111  placed on ventilators and resuscitated with lactated Ringer's solution.
112 ng dopamine (5 to 10 microg/kg) or hyperoxic lactated Ringer's solution.
113 hed blood volume was returned in the form of lactated Ringer's solution.
114 hed blood volume was returned in the form of lactated Ringer's solution.
115 ompared with its occurrence in animals given lactated Ringer's solution.
116 hed blood volume was returned in the form of lactated Ringer's solution.
117 ns in patients receiving a rapid infusion of lactated Ringer's solution.
118  (hetastarch solution); 5% human albumin; or lactated Ringer's solution.
119 olus of either hypertonic saline, Isosal, or lactated Ringer's solution.
120 stituted HDL or placebo), and then by 1 L of lactated Ringer's solution.
121 ous insulin, immunosuppressive treatment, or lactated Ringer's therapy.
122 de C positive neurons in CA1 vs. Hextend and lactated Ringer's, and CA3 vs. Hextend (p<.05).
123 ial blood pressure>50 mm Hg for 30 min) with lactated Ringer's, Hextend, or PNPH, and then shed blood
124        Balanced crystalloid solutions (e.g., lactated Ringer's, Plasma-Lyte) are an increasingly used
125  were used to guide the infusion rate of the lactated Ringer's.
126 = 8), microdialysis sites were perfused with lactated Ringer solution (Control), 40 pm, 4 nm or 400 n
127 Protocol 2 (n = 11) sites were perfused with lactated Ringer solution (Control), 400 nm ET-1, 10 mm N
128 used via intradermal microdialysis with: (1) lactated Ringer solution (Control); (2) 10 mm ascorbate
129 rfusions (1, 3, 4, 5 and 7 pmol) with either lactated Ringer solution alone, or with ET(B) R (BQ-788)
130  in the proportion of fluids administered as lactated Ringer solution compared with normal saline and
131  7.1 was induced by infusion of 0.2 M HCl in lactated Ringer solution in the acid group.
132 proportion of total fluids received that was lactated Ringer solution increased from 28% to 75% in th
133 rgeted education to encourage prescribing of lactated Ringer solution instead of normal saline.
134 anolol (Y + P), bretylium tosylate (BT), and lactated Ringer solution were infused via intradermal mi
135  vehicle control (90% propylene glycol + 10% lactated Ringer solution); (2) 20 mm capsazepine to inhi
136  and after interventions to encourage use of lactated Ringer solution.
137 injury in the PJ34-treated group than in the Lactated Ringer-treated mice at 24 hours of reperfusion.
138      Since the 1960s simple inexpensive cold lactated Ringers with additives has been used for short-

 
Page Top